ロード中...
Dectin-1-activated dendritic cells: A potent Th9 cell inducer for tumor immunotherapy
Dendritic cell (DC)-based immunotherapy has great promise for cancer treatment. We have recently demonstrated that dectin-1-activated DCs trigger potent antitumor Th9 cells in vivo. Dectin-1-activated DC-induced antitumor responses rely on the induced Th9/IL-9. These findings offer new strategies fo...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5139651/ https://ncbi.nlm.nih.gov/pubmed/27999759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1238558 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|